These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer]. Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma. Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770 [TBL] [Abstract][Full Text] [Related]
14. Tumor-associated trypsin inhibitor in patients with chronic pancreatic diseases. Plebani M; Basso D; Fabris C; Meggiato T; Del Favero G; Panozzo MP; Fogar P; Faggian D; Angonese C; Burlina A Klin Wochenschr; 1989 Oct; 67(20):1029-32. PubMed ID: 2586008 [TBL] [Abstract][Full Text] [Related]
15. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy. Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855 [TBL] [Abstract][Full Text] [Related]
17. [Significance of the the tumor markers, Ca-125 and tumor-associated trypsin inhibitor in patients with carcinoma of the cervix and uterus]. Ilić RS; Mihailović D Srp Arh Celok Lek; 1992; 120(3-4):97-9. PubMed ID: 1465666 [TBL] [Abstract][Full Text] [Related]